<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>37(28)</volume><submitter>Park HM</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>This study aimed to analyze the current trends and predict the epidemiologic features of hepatobiliary and pancreatic (HBP) cancers according to the Korea Central Cancer Registry to provide insights into health policy.&lt;h4>Methods&lt;/h4>Incidence data from 1999 to 2017 and mortality data from 2002 to 2018 were obtained from the Korea National Cancer Incidence Database and Statistics Korea, respectively. The future incidence rate from 2018 to 2040 and mortality rate from 2019 to 2040 of each HBP cancer were predicted using an age-period-cohort model. All analyses, including incidence and mortality, were stratified by sex.&lt;h4>Results&lt;/h4>From 1999 to 2017, the age-standardized incidence rate (ASIR) of HBP cancers per 100,000 population had changed (liver, 25.8 to 13.5; gallbl</pubmed_abstract><journal>Journal of Korean medical science</journal><pagination>e216</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9294502</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea.</pubmed_title><pmcid>PMC9294502</pmcid><pubmed_authors>Kim SW</pubmed_authors><pubmed_authors>Kang MJ</pubmed_authors><pubmed_authors>Jung KW</pubmed_authors><pubmed_authors>Park HM</pubmed_authors><pubmed_authors>Park SJ</pubmed_authors><pubmed_authors>Han SS</pubmed_authors><pubmed_authors>Won YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea.</name><description>&lt;h4>Background&lt;/h4>This study aimed to analyze the current trends and predict the epidemiologic features of hepatobiliary and pancreatic (HBP) cancers according to the Korea Central Cancer Registry to provide insights into health policy.&lt;h4>Methods&lt;/h4>Incidence data from 1999 to 2017 and mortality data from 2002 to 2018 were obtained from the Korea National Cancer Incidence Database and Statistics Korea, respectively. The future incidence rate from 2018 to 2040 and mortality rate from 2019 to 2040 of each HBP cancer were predicted using an age-period-cohort model. All analyses, including incidence and mortality, were stratified by sex.&lt;h4>Results&lt;/h4>From 1999 to 2017, the age-standardized incidence rate (ASIR) of HBP cancers per 100,000 population had changed (liver, 25.8 to 13.5; gallbl</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-04-18T15:37:33.32Z</modification><creation>2025-04-07T02:23:22.281Z</creation></dates><accession>S-EPMC9294502</accession><cross_references><pubmed>35851861</pubmed><doi>10.3346/jkms.2022.37.e216</doi></cross_references></HashMap>